Geographic and temporal heterogeneity in public prescription pharmaceutical expenditures in Spain

Review of Regional Studies

Volumn 38, Issue 1, 2008, Pages 89-103

  Lauridsen, Jørgen ^a   Bech, Mickael ^a   López, Fernando ^b   Sánchez, Mariluz Maté ^b  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b TECHNICAL UNIVERSITY OF CARTAGENA   (Spain)

Author keywords

Pharmaceutical expenditure; Seemingly unrelated regression; Spatial autocorrelation; Spatial expansion; Varying coefficients

Indexed keywords

AUTOCORRELATION; DRUG; EXPENDITURE; HETEROGENEITY; MACROECONOMICS; PANEL DATA; SPATIAL DATA; SPILLOVER EFFECT;

SPAIN;

EID: 77953757703     PISSN: 0048749X     EISSN: 15530892     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Anselin, Luc. (1988) Spatial Econometrics: Methods and Models. Kluwer Academic Publishers: Amsterdam.
2. Casetti, Emilio. (1997) "The Expansion Method, Mathematical Modeling, and Spatial Econometrics," International Regional Science Review, 20, 9-33.
3. Costa-Font, Joan and Jaume Puig-Junoy. (2004) "Regulatory Ambivalence and the Limitations of Pharmaceutical Policy in Spain," Faculty of Economics and Business Working Paper 762: Universitat Pompeu Fabra.
4. Darbá, Josep. (2003a) "Pharmaceutical Expenditure and Therapeutic Value of New Medicines in Spain," Pharmacoeconomics, 21, 1211-1212.
5. Darbá, Josep. (2003b) "Pharmaceutical Expenditure in Spain: Evolution and Cost Containment Measures during 1998-2001," European Journal of Health Economics, 4, 151-157.
6. Dubois, Robert W., Anita J. Chawla, Cheryl A. Neslusan, Mark W. Smith, and Sally Wade. (2000) "Explaining Drug Spending Trends: Does Perception Match Reality?" Health Affairs, 19, 231-239.
7. Dubois, Robert W., Elaine Batchlor, and Sally Wade. (2002) "Geographic Variation in the Use of Medications: Is Uniformity Good News or Bad?" Health Affairs, 21, 240-250.
8. Ess, Silvia M., Sebastian Schneeweiss, and Thomas D. Szucs. (2003) "European Healthcare Policies for Controlling Drug Expenditure," Pharmacoeconomics, 21, 89-103.
9. Folland, Sherman, Allan C. Goodman, and Miron Stano. (2003) The Economics of Health and Health Care. Prentice Hall: Upper Saddle River, New Jersey.
10. Gerdtham, Ulf-G. and Douglas Lundin. (2004) "Why Did Drug Spending Increase during the 1990s? A Decomposition Based on Swedish Data," Pharmacoeconomics, 22, 29-42.
11. Ham, Chris. (1988) "Health Care Variation: Assessing the Evidence," King's Fund Institute Working Paper: London.
12. Joines, Jerry D., Irva Hertz-Picciotto I, Timothy S. Carey, Wilbert Gesler, and Chirayath Suchindran. (2003) "A Spatial Analysis of County-level Variation in Hospitalization Rates for Low Back Problems in North Carolina," Social Science and Medicine, 56, 2541-2553.
13. Jones, John-P. and Emilio Casetti. (1992) Applications of the Expansion Method. Routledge: London.
14. Kitchener, Martin, Helen Carrillo, and Charlene Harrington. (2003) "Medicaid Community- Based Programs: A Longitudinal Analysis of State Variation in Expenditures and Utilization," Inquiry, 4, 375-389.
15. Lauridsen, Jørgen, Mickael Bech, Fernando López, and Mariluz Sánchez. (2010) "A Spatiotemporal Analysis of Public Pharmaceutical Expenditure," Annals of Regional Science, forthcoming.
16. Levaggi, Rosella and Roberto Zanola. (2003) "Flypaper Effect and Sluggishness: Evidence from Regional Health Expenditure in Italy," International Tax and Public Finance, 10, 535-547.
17. Lopez-Casasnovas, Guillem. (2005) "Economic Considerations Regarding Pharmaceutical Expenditure in Spain and its Financing," in Jaume Puig-Junoy, ed., The Public Financing of Pharmaceuticals: An Economic Approach. Edward Elgar: Cheltenham, pp. 189-208.
18. Lopez-Casasnovas, Guillem, Joan Costa-Font, and Ivan Planas. (2005) "Diversity and Regional Inequalities in the Spanish System of Health Care Services," Health Economics, 14, S221-235.
19. Lopez-Casasnovas, Guillem and Marc Saez. (2001) "A Multilevel Analysis on the Determinants of Regional Health Care Expenditure: A Note," Research Centre on Health and Economics Working Paper 572.
20. Metge, Colleen, Charlyn Black, Sandra Peterson, and Anita L. Kozyrskyj. (1999) "The Population's Use of Pharmaceuticals," Medical Care, 37, JS42-59.
21. Morgan, Steven G. (2005) "Booming Prescription Drug Expenditure-A Population-Based Analysis of Age Dynamics," Medical Care, 43, 996-1008.
22. Moscone, Francesco and Martin Knapp. (2005) "Exploring the Spatial Pattern of Mental Health Expenditure," Journal of Mental Health Policy and Economics, 8, 205-217.
23. Puig-Junoy, Jaume. (2004) "Incentives and Pharmaceutical Reimbursement Reforms in Spain," Health Policy, 67, 149-165.
24. Rovira, Joan, Ramon Tremosa, Antoni Gilabert, and Miquel Torralba. (2001) "The Role of Prices in Drug Expenditure Analysis," Health Economics in Prevention and Care, 2, 142-149.
25. Wennberg, John E. and Alan Gittelsohn. (1973) "Small Area Variation in Health-Care Delivery," Science, 182, 1102-1107.
26. Westert, Gert P., Peter P. Groenewegen, Hendriek C. Boshuizen, Peter M. M. Spreeuwenberg, and Martin P.M. Steultjens. (2004) "Medical Practice Variations in Hospital Care; Time Trends of a Spatial Phenomenon," Health & Place, 10, 215-220.
27. Zellner, Arnold. (1962) "An Efficient Method of Estimating Seemingly Unrelated Regressions and Tests of Aggregation Bias," Journal of the American Statistical Association, 57, 348-368.